She, Y. and Liu, Z. 2022. Effect of Peptide Drug Liraglutide Nano-Formulation Combined with Sodium-Glucose Cotransporter-2 Inhibitor on Blood Lipids in Patients with Type 2 Diabetes: Peptide Drug Liraglutide Nano-Formulation and Type 2 Diabetes. Cellular and Molecular Biology. 68, 3 (Mar. 2022), 221–228. DOI:https://doi.org/10.14715/cmb/2022.68.3.25.